Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

Multiple myeloma (MM) is a plasma cells neoplasm. The overexpression of Bcl-2 family proteins, particularly myeloid cell leukemia 1 (Mcl-1), plays a critical role in the pathogenesis of MM. The overexpression of Mcl-1 is associated with drug resistance and overall poor prognosis of MM. Thus, inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Odat, Omar S., von Suskil, Max, Chitren, Robert J., Elbezanti, Weam O., Srivastava, Sandeep K., Budak-Alpddogan, Tulin, Jonnalagadda, Subash C., Aggarwal, Bharat B., Pandey, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327170/
https://www.ncbi.nlm.nih.gov/pubmed/34349655
http://dx.doi.org/10.3389/fphar.2021.699629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327170/
https://www.ncbi.nlm.nih.gov/pubmed/34349655
http://dx.doi.org/10.3389/fphar.2021.699629

Ejemplares similares